{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:44:32Z","timestamp":1790016272200,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Reata Pharmaceuticals"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jdiacomp.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T08:32:44Z","timestamp":1536827564000},"page":"1113-1117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Glenn M.","family":"Chertow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald B.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie P.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Goldsberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8666-0725","authenticated-orcid":false,"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8492-3587","authenticated-orcid":false,"given":"Mark E.","family":"Molitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo E.","family":"Pergola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold L.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Spinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.jdiacomp.2018.09.005_bb0005","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1681\/ASN.2013040330","article-title":"Obesity in CKD--what should nephrologists know?","volume":"11","author":"Stenvinkel","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.jdiacomp.2018.09.005_bb0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ekir.2017.01.009","article-title":"The Obesity Paradox in Kidney Disease: How to Reconcile it with Obesity Management","volume":"2","author":"Kalantar-Zadeh","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"112","key":"10.1016\/j.jdiacomp.2018.09.005_bb0015","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"12","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.jdiacomp.2018.09.005_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.hjr.0000114707.27531.48","article-title":"The obesity epidemic, metabolic syndrome and future prevention strategies","volume":"1","author":"James","year":"2004","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"114","key":"10.1016\/j.jdiacomp.2018.09.005_bb0025","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"12","author":"Furukawa","year":"2004","journal-title":"J Clin Invest"},{"issue":"620","key":"10.1016\/j.jdiacomp.2018.09.005_bb0030","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2009.08.022","article-title":"Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-Imidazolide","author":"Shin","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"285","key":"10.1016\/j.jdiacomp.2018.09.005_bb0035","doi-asserted-by":"crossref","first-page":"40581","DOI":"10.1074\/jbc.M110.176545","article-title":"The triterpenoid CDDO-Me has potent antidiabetic effects in diet-induced diabetic mice and Leprdb\/db mice","author":"Saha","year":"2010","journal-title":"J Biol Chem"},{"issue":"325","key":"10.1016\/j.jdiacomp.2018.09.005_bb0040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/jpet.107.135822","article-title":"NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet","volume":"2","author":"Tanaka","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"60","key":"10.1016\/j.jdiacomp.2018.09.005_bb0045","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/db10-1164","article-title":"Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo","volume":"2","author":"Tan","year":"2011","journal-title":"Diabetes"},{"issue":"21","key":"10.1016\/j.jdiacomp.2018.09.005_bb0050","first-page":"275A","article-title":"Targeting Keap1-Nrf2 Pathway Ameliorates Renal Inflammation and Fibrosis in Mice with Protein-Overload Proteinuria","author":"Zoja","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"300","key":"10.1016\/j.jdiacomp.2018.09.005_bb0055","doi-asserted-by":"crossref","first-page":"F1180","DOI":"10.1152\/ajprenal.00353.2010","article-title":"Bardoxolone Methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes - Nrf2, PPAR{gamma}, and HO-1","author":"Wu","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"231","key":"10.1016\/j.jdiacomp.2018.09.005_bb0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.taap.2008.05.022","article-title":"Coordinated induction of Nrf2 target genes protects against iron nitrilotriacetate (FeNTA)-induced nephrotoxicity","volume":"3","author":"Tanaka","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"issue":"335","key":"10.1016\/j.jdiacomp.2018.09.005_bb0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.110.170084","article-title":"Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity","volume":"1","author":"Aleksunes","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"74","key":"10.1016\/j.jdiacomp.2018.09.005_bb0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1021\/np100826q","article-title":"New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress","volume":"3","author":"Sporn","year":"2011","journal-title":"J Nat Prod"},{"issue":"83","key":"10.1016\/j.jdiacomp.2018.09.005_bb0075","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"6","author":"Ruiz","year":"2013","journal-title":"Kidney Int"},{"issue":"33","key":"10.1016\/j.jdiacomp.2018.09.005_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000327599","article-title":"Effect of Bardoxolone on Kidney Function in Patients with T2D and Stage 3b - 4 CKD","author":"Pergola","year":"2011","journal-title":"Am J Nephrol"},{"issue":"365","key":"10.1016\/j.jdiacomp.2018.09.005_bb0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"4","author":"Pergola","year":"2011","journal-title":"N Engl J Med"},{"issue":"369","key":"10.1016\/j.jdiacomp.2018.09.005_bb0090","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"26","author":"de Zeeuw","year":"2013","journal-title":"N Engl J Med"},{"issue":"28","key":"10.1016\/j.jdiacomp.2018.09.005_bb0095","first-page":"B1","article-title":"Bardoxolone Methyl Improved GFR Measured by Standard Inulin Clearance: The TSUBAKI Study","author":"Nangaku","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.jdiacomp.2018.09.005_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13539-012-0079-1","article-title":"Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature","volume":"1","author":"Patel","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"37","key":"10.1016\/j.jdiacomp.2018.09.005_bb0105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000346948","article-title":"Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)","volume":"3","author":"de Zeeuw","year":"2013","journal-title":"Am J Nephrol"},{"issue":"28","key":"10.1016\/j.jdiacomp.2018.09.005_bb0110","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/ndt\/gft445","article-title":"Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial","volume":"11","author":"Lambers Heerspink","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"2015","key":"10.1016\/j.jdiacomp.2018.09.005_bb0115","doi-asserted-by":"crossref","first-page":"549352","DOI":"10.1155\/2015\/549352","article-title":"Bardoxolone Methyl Prevents Mesenteric Fat Deposition and Inflammation in High-Fat Diet Mice","author":"Dinh","year":"2015","journal-title":"Sci World J"},{"key":"10.1016\/j.jdiacomp.2018.09.005_bb0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2015.11.018","article-title":"Bardoxolone methyl prevents the development and progression of cardiac and renal pathophysiologies in mice fed a high-fat diet","volume":"243","author":"Camer","year":"2016","journal-title":"Chem Biol Interact"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872718308110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872718308110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T04:54:00Z","timestamp":1751864040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872718308110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1056872718308110"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.09.005","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors.","name":"copyright","label":"Copyright"}]}}